Skip to main content

Advertisement

Log in

Albumin-Derived NLR Score is a Novel Prognostic Marker for Esophageal Squamous Cell Carcinoma

  • Thoracic Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Multidisciplinary treatment for esophageal squamous cell carcinoma (ESCC) has improved outcomes, but the prognosis for ESCC remains poor. Nutritional and inflammatory indicators are reported to be associated with cancer prognosis. The combination of albumin and the derived neutrophil-to-lymphocyte ratio (Alb-dNLR) score was established to measure the immune system and nutritional status. The authors hypothesized that the Alb-dNLR score could be a new reliable prognostic factor for ESCC patients.

Methods

The study evaluated 269 patients who underwent esophagectomy between April 2010 and March 2018, including 185 patients who received neoadjuvant chemotherapy. The Alb-dNLR score was calculated using serum albumin and the dNLR. The dNLR was calculated as neutrophils to (leukocyte-neutrophil count). The cutoff values of the albumin and dNLR for overall survival (OS) were determined using the receiver operating characteristic curve. Patients were divided into “high” and “low” groups according to the Alb-dNLR score.

Results

A high Alb-dNLR score was found in 61 cases (22.7%). The 5-year OS was 34% in the high Alb-dNLR group and 66.2% in the low Alb-dNLR group (p < 0.0001). The 5-year cause-specific survival (CSS) was 51.5% in the high Alb-dNLR group and 74.7% in the low Alb-dNLR group (p < 0.0001). Multivariate analyses demonstrated that the Alb-dNLR score was an independent prognostic factor for OS (hazard ratio [HR], 2.198; 95% confidence interval [CI], 1.460–3.263; p = 0.0002) and CSS (HR, 1.733; 95% CI, 1.035–2.835; p = 0.0371).

Conclusions

The Alb-dNLR score is an extremely useful, easy-to-use parameter to predict OS and CSS for ESCC patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.

    Article  PubMed  Google Scholar 

  2. Zhang X, Jiang Y, Wang Y, et al. Prognostic role of neutrophil-lymphocyte ratio in esophageal cancer: a systematic review and meta-analysis. Med Baltim. 2018;97:e13585.

  3. Yodying H, Matsuda A, Miyashita M, et al. Prognostic significance of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in oncologic outcomes of esophageal cancer: a systematic review and meta-analysis. Ann Surg Oncol. 2016;23:646–54.

    Article  PubMed  Google Scholar 

  4. Hirahara N, Tajima Y, Fujii Y, et al. Preoperative prognostic nutritional index predicts long-term surgical outcomes in patients with esophageal squamous cell carcinoma. World J Surg. 2018;42:2199–208.

    Article  PubMed  Google Scholar 

  5. Kosumi K, Baba Y, Ishimoto T, et al. Neutrophil/lymphocyte ratio predicts the prognosis in esophageal squamous cell carcinoma patients. Surg Today. 2016;46:405–13.

    Article  CAS  PubMed  Google Scholar 

  6. Zhang H, Shang X, Ren P, et al. The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma. J Cell Physiol. 2019;234:1794–802.

    Article  CAS  PubMed  Google Scholar 

  7. Xue Y, Zhou X, Xue L, Zhou R, Luo J. The role of pretreatment prognostic nutritional index in esophageal cancer: a meta-analysis. J Cell Physiol. 2019;234:19655–62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Wang Y, Chen L, Wu Y, Li P, Che G. The prognostic value of modified Glasgow prognostic score in patients with esophageal squamous cell cancer: a meta-analysis. Nutr Cancer. 2020;72:1146–54.

    Article  CAS  PubMed  Google Scholar 

  9. McSorley ST, Lau HYN, McIntosh D, Forshaw MJ, McMillan DC, Crumley AB. Staging the tumor and staging the host: pretreatment combined neutrophil lymphocyte ratio and modified glasgow prognostic score is associated with overall survival in patients with esophagogastric cancers undergoing treatment with curative intent. Ann Surg Oncol. 2021;28:722–31.

    Article  PubMed  Google Scholar 

  10. Jomrich G, Paireder M, Kristo I, et al. High systemic immune-inflammation index is an adverse prognostic factor for patients with gastroesophageal adenocarcinoma. Ann Surg. 2021;273:532–41.

    Article  PubMed  Google Scholar 

  11. Takagi K, Buettner S, Ijzermans JNM, Wijnhoven BPL. Systematic review on the controlling nutritional status (CONUT) score in patients undergoing esophagectomy for esophageal cancer. Anticancer Res. 2020;40:5343–9.

    Article  CAS  PubMed  Google Scholar 

  12. Sakai M, Sohda M, Saito H, et al. Comparative analysis of immunoinflammatory and nutritional measures in surgically resected esophageal cancer: a single-center retrospective study. In Vivo. 2020;34:881–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Matsuda S, Takeuchi H, Kawakubo H, et al. Validation study of fibrinogen and albumin score in esophageal cancer patients who underwent esophagectomy: multicenter prospective cohort study. Ann Surg Oncol. 2021;28:774–84.

    Article  PubMed  Google Scholar 

  14. Proctor MJ, McMillan DC, Morrison DS, Fletcher CD, Horgan PG, Clarke SJ. A derived neutrophil-to-lymphocyte ratio predicts survival in patients with cancer. Br J Cancer. 2012;107:695–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Chen S, Ying H, Du J, et al. The association between albumin-dNLR score and disease activity in patients with rheumatoid arthritis. J Clin Lab Anal. 2019;33:e22695.

  16. Brierley J, Gospodarowicz MK, Wittekind C, Sauvage M, Union internationale contre le c. TNM classification des tumeurs malignes. 2017.

  17. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240:205–13.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Hajian-Tilaki K. Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation. Caspian J Intern Med. 2013;4:627–35.

    PubMed  PubMed Central  Google Scholar 

  19. Park SH, Goo JM, Jo CH. Receiver operating characteristic (ROC) curve: practical review for radiologists. Korean J Radiol. 2004;5:11–8.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Donskov F. Immunomonitoring and prognostic relevance of neutrophils in clinical trials. Semin Cancer Biol. 2013;23:200–7.

    Article  CAS  PubMed  Google Scholar 

  22. Germano G, Allavena P, Mantovani A. Cytokines as a key component of cancer-related inflammation. Cytokine. 2008;43:374–9.

    Article  CAS  PubMed  Google Scholar 

  23. Templeton AJ, McNamara MG, Šeruga B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106:dju124.

  24. Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013;88:218–30.

    Article  PubMed  Google Scholar 

  25. Chen M-F, Chen P-T, Kuan F-C, Chen W-C. The predictive value of pretreatment neutrophil-to-lymphocyte ratio in esophageal squamous cell carcinoma. Ann Surg Oncol. 2019;26:190–9.

    Article  PubMed  Google Scholar 

  26. Gao GD, Sun B, Wang XB, Wang SM. Neutrophil-to-lymphocyte ratio as prognostic indicator for patients with esophageal squamous cell cancer. Int J Biol Markers. 2017;32:e409–14.

    Article  PubMed  Google Scholar 

  27. Barbetta A, Nobel TB, Sihag S, et al. Neutrophil-to-lymphocyte ratio as predictor of treatment response in esophageal squamous cell cancer. Ann Thorac Surg. 2018;106:864–71.

    Article  PubMed  PubMed Central  Google Scholar 

  28. McLaren PJ, Bronson NW, Hart KD, et al. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios can predict treatment response to neoadjuvant therapy in esophageal cancer. J Gastrointest Surg. 2017;21:607–13.

    Article  PubMed  Google Scholar 

  29. Sharaiha RZ, Halazun KJ, Mirza F, et al. Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer. Ann Surg Oncol. 2011;18:3362–9.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Kato T, Oshikiri T, Urakawa N, et al. Preoperative neutrophil-to-lymphocyte ratio predicts the prognosis of esophageal squamous cell cancer patients undergoing minimally invasive esophagectomy after neoadjuvant chemotherapy. J Surg Oncol. 2021. In press.

  31. Grenader T, Nash S, Adams R, et al. Derived neutrophil-lymphocyte ratio is predictive of survival from intermittent therapy in advanced colorectal cancer: a post hoc analysis of the MRC COIN study. Br J Cancer. 2016;114:612–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Absenger G, Szkandera J, Pichler M, et al. A derived neutrophil-to-lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients. Br J Cancer. 2013;109:395–400.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Szkandera J, Stotz M, Eisner F, et al. External validation of the derived neutrophil-to-lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patients. PLoS ONE. 2013;8:e78225.

  34. Dirican A, Kucukzeybek BB, Alacacioglu A, et al. Do the derived neutrophil-to-lymphocyte ratio and the neutrophil-to-lymphocyte ratio predict prognosis in breast cancer? Int J Clin Oncol. 2015;20:70–81.

    Article  CAS  PubMed  Google Scholar 

  35. Troppan K, Deutsch A, Gerger A, et al. The derived neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with diffuse large B-cell lymphoma. Br J Cancer. 2014;110:369–74.

    Article  CAS  PubMed  Google Scholar 

  36. Wu YY, Qin YY, Qin JQ, Zhang X, Lin FQ. Diagnostic value of derived neutrophil-to-lymphocyte ratio in patients with ovarian cancer. J Clin Lab Anal. 2019;33:e22833.

  37. Cox S, Hurt C, Grenader T, Mukherjee S, Bridgewater J, Crosby T. The prognostic value of derived neutrophil-to-lymphocyte ratio in oesophageal cancer treated with definitive chemoradiotherapy. Radiother Oncol. 2017;125:154–9.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Mariette C, De Botton ML, Piessen G. Surgery in esophageal and gastric cancer patients: what is the role for nutrition support in your daily practice? Ann Surg Oncol. 2012;19:2128–34.

    Article  PubMed  Google Scholar 

  39. van der Schaaf MK, Tilanus HW, van Lanschot JJ, et al. The influence of preoperative weight loss on the postoperative course after esophageal cancer resection. J Thorac Cardiovasc Surg. 2014;147:490–5.

    Article  PubMed  Google Scholar 

  40. Zhang S, Tan Y, Cai X, Luo K, Wu Z, Lu J. Preoperative weight loss is associated with poorer prognosis in operable esophageal cancer patients: a single-center retrospective analysis of a large cohort of Chinese patients. J Cancer. 2020;11:1994–9.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Chandrasinghe PC, Ediriweera DS, Kumarage SK, Deen KI. Preoperative hypoalbuminaemia predicts poor overall survival in rectal cancer: a retrospective cohort analysis. BMC Clin Pathol. 2013;13:1–5.

    Article  Google Scholar 

  42. Crumley ABC, Stuart RC, McKernan M, McMillan DC. Is hypoalbuminemia an independent prognostic factor in patients with gastric cancer? World J Surg. 2010;34:2393–8.

    Article  PubMed  Google Scholar 

  43. Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr J. 2010;9:69.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Nakamura M, Iwahashi M, Nakamori M, et al. A new prognostic score for the survival of patients with esophageal squamous cell carcinoma. Surg Today. 2014;44:875–83.

    Article  CAS  PubMed  Google Scholar 

  45. Liu JX, Li A, Zhou LY, et al. Significance of combined preoperative serum Alb and dNLR for diagnosis of pancreatic cancer. Future Oncol Lond Engl. 2018;14:229–39.

    Article  CAS  Google Scholar 

  46. Sun X, Wang J, Liu J, Chen S, Liu X. Albumin concentrations plus neutrophil lymphocyte ratios for predicting overall survival after curative resection for gastric cancer. Onco Targets Ther. 2016;9:4661–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Rondanelli M, Klersy C, Terracol G, et al. Whey protein, amino acids, and vitamin D supplementation with physical activity increases fat-free mass and strength, functionality, and quality of life and decreases inflammation in sarcopenic elderly. Am J Clin Nutr. 2016;103:830–40.

    Article  CAS  PubMed  Google Scholar 

  48. Caldo-Silva A, Furtado GE, Chupel MU, et al. Effect of training-detraining phases of multicomponent exercises and BCAA supplementation on inflammatory markers and albumin levels in frail older persons. Nutrients. 2021;13:1106.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Ding D, Feng Y, Song B, Gao S, Zhao J. Effects of preoperative and postoperative enteral nutrition on postoperative nutritional status and immune function of gastric cancer patients. Turk J Gastroenterol. 2015;26:181–5.

    Article  PubMed  Google Scholar 

  50. Trépanier M, Minnella EM, Paradis T, et al. Improved disease-free survival after prehabilitation for colorectal cancer surgery. Ann Surg. 2019;270:493–501.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Taro Oshikiri MD.

Ethics declarations

Disclosure

There are no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abe, T., Oshikiri, T., Goto, H. et al. Albumin-Derived NLR Score is a Novel Prognostic Marker for Esophageal Squamous Cell Carcinoma. Ann Surg Oncol 29, 2663–2671 (2022). https://doi.org/10.1245/s10434-021-11012-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-021-11012-y

Navigation